Andrea Calandrino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andrea Calandrino has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Lucio Antonio Ramenghi
Istituto Giannina Gaslini, Genoa, Italy; Department of Neuroscience , Rehabilitation , Ophthalmology , Genetics , Maternal and Child Health, University of Genoa, Genoa, Italy, Italy
18 shared publications - Francesco Vinci
Neonatal Intensive Care Unit, Istituto Giannina Gaslini, Genoa, Italy, Italy
12 shared publications - Pasquale Striano
IRCCS Istituto Giannina Gaslini Genova Italy
9 shared publications - Maria Ester Canepa
Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics and Mother-Child Health, University of Genoa, 16132 Genoa, Italy
6 shared publications - Samuele Caruggi
Neonatal Intensive Care Unit IRCCS Istituto Giannina Gaslini Genoa Italy
6 shared publications - Alessia Pepe
Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Mother and Child Health, School of Medical and Pharmaceuticals, University of Genoa, 16132 Genoa, Italy
5 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (11) , 1401
Beyond Numerical Thresholds: A Systems-Level Perspective on Dysglycaemia and the Liver–Brain Axis in Brain Injury
Glucose is more than an energetic substrate: its homeostasis emerges from continuous interactions between peripheral glucose-regulatory organs and the brain, where glucose availability, sensing, and utilisation must be dynamically matched to metabolic demands. This narrative review examines how disruption of this balance may intersect with oxidative stress, inflammation, and brain vulnerability at the extremes of life. In preterm neonates, the definition of pathological glycaemic states remains heterogeneous, while hypoglycaemia, hyperglycaemia, and particularly glycaemic variability may represent different manifestations of dysglycaemia within an immature homeostatic system. Experimental and clinical evidence links these disturbances, with different degrees of certainty, to oxidative stress, inflammatory responses, adverse neurological outcomes, and white matter vulnerability. The developing brain is particularly susceptible to redox imbalance because of maturation-dependent antioxidant defences and the vulnerability of developing white matter. At the opposite extreme of life, ageing is accompanied by alterations in cerebral glucose and energy metabolism, while neurodegenerative disorders show disturbances in glucose transport and utilisation together with mitochondrial dysfunction, oxidative stress, inflammation, and neuronal and white matter abnormalities. We propose the Biochemical and Physiological Mirror as a conceptual interpretation of these apparently distant conditions: developmental immaturity and age-related decline represent distinct biological trajectories that may converge on partially shared glucose–redox–inflammatory intersections. Within the Crossword Effect, glucose therefore acquires biological meaning not as an isolated concentration but through its context-dependent relationships with metabolic, redox, inflammatory, cellular, and developmental information. Viewing dysglycaemia as a systems-level disturbance rather than solely as deviation from a numerical threshold may provide a more integrated framework for understanding brain vulnerability across the lifespan.
- 29 October 2026
- Published by MDPI AG in Antioxidants
- Vol. 15 (11) , 1401
Open AccessBeyond Numerical Thresholds: A Systems-Level Perspective on Dysglycaemia and the Liver–Brain Axis in Brain Injury
Glucose is more than an energetic substrate: its homeostasis emerges from continuous interactions between peripheral glucose-regulatory organs and the brain, where glucose availability, sensing, and utilisation must be dynamically matched to metabolic demands. This narrative review examines how disruption of this balance may intersect with oxidative stress, inflammation, and brain vulnerability at the extremes of life. In preterm neonates, the definition of pathological glycaemic states remains heterogeneous, while hypoglycaemia, hyperglycaemia, and particularly glycaemic variability may represent different manifestations of dysglycaemia within an immature homeostatic system. Experimental and clinical evidence links these disturbances, with different degrees of certainty, to oxidative stress, inflammatory responses, adverse neurological outcomes, and white matter vulnerability. The developing brain is particularly susceptible to redox imbalance because of maturation-dependent antioxidant defences and the vulnerability of developing white matter. At the opposite extreme of life, ageing is accompanied by alterations in cerebral glucose and energy metabolism, while neurodegenerative disorders show disturbances in glucose transport and utilisation together with mitochondrial dysfunction, oxidative stress, inflammation, and neuronal and white matter abnormalities. We propose the Biochemical and Physiological Mirror as a conceptual interpretation of these apparently distant conditions: developmental immaturity and age-related decline represent distinct biological trajectories that may converge on partially shared glucose–redox–inflammatory intersections. Within the Crossword Effect, glucose therefore acquires biological meaning not as an isolated concentration but through its context-dependent relationships with metabolic, redox, inflammatory, cellular, and developmental information. Viewing dysglycaemia as a systems-level disturbance rather than solely as deviation from a numerical threshold may provide a more integrated framework for understanding brain vulnerability across the lifespan.
- Open Access
- 28 October 2026
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
MRI BRAIN lesions and growth after antenatal steroids in preterm infants: Does timing matter?
Introduction: Antenatal corticosteroids (ACS) are widely used to improve outcomes in preterm infants, with known benefits on respiratory morbidity and intraventricular hemorrhage (IVH). However, the effect of ACS timing on brain injury and development remains unclear. We aimed to evaluate the impact of a complete course of ACS (ccACS), with particular attention to timing, on brain lesions, growth, and neurodevelopment in very low birth weight (VLBW) infants using magnetic resonance imaging (MRI). Material and Methods: In this historical cohort study, all VLBW infants admitted to a tertiary neonatal intensive care unit between January 2019 and December 2021 were included. Clinical data, including timing of ACS administration, were collected. The primary outcome was the occurrence of brain injury on MRI at term‐equivalent age, including IVH, white matter lesions (WML), and cerebellar hemorrhage (CBH). Secondary outcomes were brain growth and maturation on MRI and neurodevelopment at 2 years assessed using the Griffiths Mental Development Scales. Outcomes were compared between infants with and without ccACS and according to different administration‐to‐birth intervals. Results: A total of 189 infants were included, of whom 139 (73.5%) received ccACS. Infants exposed to ccACS had a lower incidence of WML ( p = 0.02) and moderate/severe IVH ( p = 0.04). In extremely preterm infants (p = 0.006). No significant differences were observed in brain growth, maturation, or neurodevelopmental outcomes at 2 years. Conclusions: A complete course of ACS was associated with unadjusted lower rates of brain injury in VLBW infants, particularly when administered within 7 days before birth in extremely preterm infants, without adverse effects on brain growth, maturation, or neurodevelopment at 2 years.
- 28 October 2026
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
Open AccessMRI BRAIN lesions and growth after antenatal steroids in preterm infants: Does timing matter?
Introduction: Antenatal corticosteroids (ACS) are widely used to improve outcomes in preterm infants, with known benefits on respiratory morbidity and intraventricular hemorrhage (IVH). However, the effect of ACS timing on brain injury and development remains unclear. We aimed to evaluate the impact of a complete course of ACS (ccACS), with particular attention to timing, on brain lesions, growth, and neurodevelopment in very low birth weight (VLBW) infants using magnetic resonance imaging (MRI). Material and Methods: In this historical cohort study, all VLBW infants admitted to a tertiary neonatal intensive care unit between January 2019 and December 2021 were included. Clinical data, including timing of ACS administration, were collected. The primary outcome was the occurrence of brain injury on MRI at term‐equivalent age, including IVH, white matter lesions (WML), and cerebellar hemorrhage (CBH). Secondary outcomes were brain growth and maturation on MRI and neurodevelopment at 2 years assessed using the Griffiths Mental Development Scales. Outcomes were compared between infants with and without ccACS and according to different administration‐to‐birth intervals. Results: A total of 189 infants were included, of whom 139 (73.5%) received ccACS. Infants exposed to ccACS had a lower incidence of WML ( p = 0.02) and moderate/severe IVH ( p = 0.04). In extremely preterm infants (p = 0.006). No significant differences were observed in brain growth, maturation, or neurodevelopmental outcomes at 2 years. Conclusions: A complete course of ACS was associated with unadjusted lower rates of brain injury in VLBW infants, particularly when administered within 7 days before birth in extremely preterm infants, without adverse effects on brain growth, maturation, or neurodevelopment at 2 years.
- Open Access
The Preterm Brain Is Also What It Eats: A Systematic Review of Nutrition and Neuroimaging Outcomes in Preterm Infants
Background: Nutrition is one of the most modifiable determinants of brain development in preterm infants. Although increasing evidence supports associations between early nutritional exposures and neurodevelopment, studies remain heterogeneous regarding nutritional interventions, imaging biomarkers, and long-term outcomes. This systematic review aimed to summarize contemporary evidence on the relationship between nutrition and brain development in preterm infants using neuroimaging as the primary assessment tool while proposing an integrated translational framework to guide future research. Methods: Following a PECO framework, a systematic literature search was conducted in PubMed, Scopus, and CINAHL: population, infants born before 37 completed weeks of gestation; exposure, any enteral or parenteral nutritional exposure, supplementation strategy, fortification approach, or individualized nutritional intervention; comparator, an alternative nutritional strategy, lower or absent exposure, standard care or, when relevant, a term-born reference group; outcomes, MRI- or CUS-based measures of brain growth, maturation, connectivity, or injury. Studies reporting volumetric, morphometric, diffusion, connectivity, spectroscopy, or quantitative ultrasound outcomes were eligible. The methodology was adapted from the PROSPERO-registered review by Ottolini et al. Original studies published between 2020 and 2026 (1 January 2020–4 September 2026) evaluating nutritional exposures or interventions in preterm infants with magnetic resonance imaging (MRI) and/or cranial ultrasound (CUS) outcomes were included. Risk of bias was assessed using the Newcastle–Ottawa Scale (NOS), ROBINS-I and RoB 2 according to study design. Quantitative imaging studies were screened for eligibility for ATLAS assessment. Given the substantial heterogeneity in nutritional exposures, imaging protocols, timing of assessments, and neurodevelopmental outcomes, meta-analysis was not performed. Certainty of evidence was assessed at the level of each causal question and neuroimaging outcome domain using the GRADE framework. Randomized intervention evidence and observational exposure evidence were evaluated according to the design and target contrast contributing to each body of evidence. Judgments considered risk of bias, inconsistency, indirectness, imprecision, publication bias, and, where applicable, factors that could increase certainty. Statistical significance was not used to determine certainty, and studies arising from shared or partially overlapping parent populations were not counted as independent replication. Results: We found 33 reports that met the inclusion criteria: 4 evaluated randomized treatment contrasts, 5 non-randomized intervention comparisons, and 24 observational nutritional exposure analyses. Greater exposure to human milk and selected strategies involving early protein and lipid provision, docosahexaenoic acid, omega-3 fatty acids, and individualized nutritional support were associated in several studies with favorable MRI measurements, including larger total or regional brain volumes, more advanced white-matter maturation, and differences in structural or functional connectivity. Some studies also reported associations with later neurodevelopment. However, findings were not uniform, and GRADE certainty across outcome-specific nutrition–neuroimaging questions ranged from very low to low, principally because of risk of bias, imprecision, heterogeneous exposure and imaging definitions, and limited independent replication. Although causal inference cannot be directly drawn, neuroimaging may provide quantitative measures of brain development that can be investigated alongside long-term neurodevelopmental outcomes. We propose the Roadmap for Imaging-Guided Enhancement of Neurodevelopment (RIGEL), an integrative research framework combining imaging, molecular biomarkers, standardized neurodevelopmental assessment, and epidemiological evidence across developmental stages. RIGEL should be regarded as a hypothesis-generating research framework that requires prospective validation before any clinical implementation.
Open AccessThe Preterm Brain Is Also What It Eats: A Systematic Review of Nutrition and Neuroimaging Outcomes in Preterm Infants
Background: Nutrition is one of the most modifiable determinants of brain development in preterm infants. Although increasing evidence supports associations between early nutritional exposures and neurodevelopment, studies remain heterogeneous regarding nutritional interventions, imaging biomarkers, and long-term outcomes. This systematic review aimed to summarize contemporary evidence on the relationship between nutrition and brain development in preterm infants using neuroimaging as the primary assessment tool while proposing an integrated translational framework to guide future research. Methods: Following a PECO framework, a systematic literature search was conducted in PubMed, Scopus, and CINAHL: population, infants born before 37 completed weeks of gestation; exposure, any enteral or parenteral nutritional exposure, supplementation strategy, fortification approach, or individualized nutritional intervention; comparator, an alternative nutritional strategy, lower or absent exposure, standard care or, when relevant, a term-born reference group; outcomes, MRI- or CUS-based measures of brain growth, maturation, connectivity, or injury. Studies reporting volumetric, morphometric, diffusion, connectivity, spectroscopy, or quantitative ultrasound outcomes were eligible. The methodology was adapted from the PROSPERO-registered review by Ottolini et al. Original studies published between 2020 and 2026 (1 January 2020–4 September 2026) evaluating nutritional exposures or interventions in preterm infants with magnetic resonance imaging (MRI) and/or cranial ultrasound (CUS) outcomes were included. Risk of bias was assessed using the Newcastle–Ottawa Scale (NOS), ROBINS-I and RoB 2 according to study design. Quantitative imaging studies were screened for eligibility for ATLAS assessment. Given the substantial heterogeneity in nutritional exposures, imaging protocols, timing of assessments, and neurodevelopmental outcomes, meta-analysis was not performed. Certainty of evidence was assessed at the level of each causal question and neuroimaging outcome domain using the GRADE framework. Randomized intervention evidence and observational exposure evidence were evaluated according to the design and target contrast contributing to each body of evidence. Judgments considered risk of bias, inconsistency, indirectness, imprecision, publication bias, and, where applicable, factors that could increase certainty. Statistical significance was not used to determine certainty, and studies arising from shared or partially overlapping parent populations were not counted as independent replication. Results: We found 33 reports that met the inclusion criteria: 4 evaluated randomized treatment contrasts, 5 non-randomized intervention comparisons, and 24 observational nutritional exposure analyses. Greater exposure to human milk and selected strategies involving early protein and lipid provision, docosahexaenoic acid, omega-3 fatty acids, and individualized nutritional support were associated in several studies with favorable MRI measurements, including larger total or regional brain volumes, more advanced white-matter maturation, and differences in structural or functional connectivity. Some studies also reported associations with later neurodevelopment. However, findings were not uniform, and GRADE certainty across outcome-specific nutrition–neuroimaging questions ranged from very low to low, principally because of risk of bias, imprecision, heterogeneous exposure and imaging definitions, and limited independent replication. Although causal inference cannot be directly drawn, neuroimaging may provide quantitative measures of brain development that can be investigated alongside long-term neurodevelopmental outcomes. We propose the Roadmap for Imaging-Guided Enhancement of Neurodevelopment (RIGEL), an integrative research framework combining imaging, molecular biomarkers, standardized neurodevelopmental assessment, and epidemiological evidence across developmental stages. RIGEL should be regarded as a hypothesis-generating research framework that requires prospective validation before any clinical implementation.
- Open Access
- 13 October 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (10) , 774
The Glial Coupling in the Developing Brain: Astrocytes, Oligodendrocytes and Myelin Formation
Astrocytes and oligodendrocytes contribute to the metabolic, homeostatic and structural organization of the developing brain, yet their interactions evolve across development and remain incompletely characterized during the earliest stages of life. This narrative review examines astrocyte–oligodendrocyte coupling in relation to myelin development and addresses the question of which cellular and metabolic mechanisms support oligodendrocyte maturation and white-matter metabolism before mature astrocytic functions are fully established. Evidence from preterm and ill term neonates is considered together with experimental and adult or elderly studies used exclusively for secondary mechanistic comparison. Astrocytes and oligodendrocytes participate in interconnected metabolic, developmental and homeostatic processes, while perinatal white-matter injury may combine reactive astrogliosis, pre-oligodendrocyte injury and maturation arrest. Neuroimaging, including quantitative susceptibility mapping, synthetic MRI, cranial ultrasound and molecular or myelin-sensitive imaging, provides complementary but indirect information on the structural and maturational consequences of these processes, whereas omics approaches may characterize their molecular environment. Radiomics similarly provides indirect tissue-level biomarkers rather than cell-specific measures of glial biology. Dysglycaemia further illustrates the dependence of developing white matter on coordinated cellular energy handling and the potential relevance of immature astrocyte–oligodendrocyte interactions during metabolic instability. Evidence from very early development suggests that oligodendrocyte maturation occurs within a changing cellular environment in which astroglial maturation, neuronal and vascular processes, and immune and metabolic mechanisms coexist. The Crossword and Foil Effects are proposed as hypothesis-generating frameworks to organize these intersecting developmental, metabolic, cellular, imaging and molecular dimensions rather than as experimentally validated causal models. Overall, no single cellular substitute for mature astrocytic functions is identified; instead, oligodendrocyte maturation appears to emerge within a developmentally changing division of metabolic, homeostatic and signaling labour across astroglial, neuronal, vascular and immune compartments.
- 13 October 2026
- Published by MDPI AG in Metabolites
- Vol. 16 (10) , 774
Open AccessThe Glial Coupling in the Developing Brain: Astrocytes, Oligodendrocytes and Myelin Formation
Astrocytes and oligodendrocytes contribute to the metabolic, homeostatic and structural organization of the developing brain, yet their interactions evolve across development and remain incompletely characterized during the earliest stages of life. This narrative review examines astrocyte–oligodendrocyte coupling in relation to myelin development and addresses the question of which cellular and metabolic mechanisms support oligodendrocyte maturation and white-matter metabolism before mature astrocytic functions are fully established. Evidence from preterm and ill term neonates is considered together with experimental and adult or elderly studies used exclusively for secondary mechanistic comparison. Astrocytes and oligodendrocytes participate in interconnected metabolic, developmental and homeostatic processes, while perinatal white-matter injury may combine reactive astrogliosis, pre-oligodendrocyte injury and maturation arrest. Neuroimaging, including quantitative susceptibility mapping, synthetic MRI, cranial ultrasound and molecular or myelin-sensitive imaging, provides complementary but indirect information on the structural and maturational consequences of these processes, whereas omics approaches may characterize their molecular environment. Radiomics similarly provides indirect tissue-level biomarkers rather than cell-specific measures of glial biology. Dysglycaemia further illustrates the dependence of developing white matter on coordinated cellular energy handling and the potential relevance of immature astrocyte–oligodendrocyte interactions during metabolic instability. Evidence from very early development suggests that oligodendrocyte maturation occurs within a changing cellular environment in which astroglial maturation, neuronal and vascular processes, and immune and metabolic mechanisms coexist. The Crossword and Foil Effects are proposed as hypothesis-generating frameworks to organize these intersecting developmental, metabolic, cellular, imaging and molecular dimensions rather than as experimentally validated causal models. Overall, no single cellular substitute for mature astrocytic functions is identified; instead, oligodendrocyte maturation appears to emerge within a developmentally changing division of metabolic, homeostatic and signaling labour across astroglial, neuronal, vascular and immune compartments.
- Open Access
- 2 October 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1847988
Impact of antenatal corticosteroid exposure on glycemic control in preterm infants assessed by continuous glucose monitoring: preliminary results from a single center study
Background: Antenatal corticosteroids (ACS) are routinely administered to women at risk of preterm delivery to improve neonatal respiratory outcomes. However, ACS exposure has been associated with neonatal hypoglycemia, and its impact on overall glycemic control and variability—particularly at earlier gestational ages—remains incompletely defined. Objectives: To evaluate glycemic control using continuous glucose monitoring (CGM) in preterm infants exposed to ACS and to assess the influence of timing of administration and gestational age on glycemic patterns. Methods: This prospective single-center cohort study included preterm infants born at 7 days) and gestational age (<34 vs ≥34 weeks). Statistical significance was adjusted using the Benjamini–Hochberg procedure. Results: Sixty-four infants were included (41 complete ACS, 15 partial ACS, 8 no ACS). Baseline characteristics were comparable among groups. During the first day of life, hypoglycemic events occurred exclusively in infants exposed to a complete course of ACS (p = 0.005), predominantly in those exposed within seven days prior to delivery. This difference was not observed on the second day. Hyperglycemic events were significantly more frequent in infants born before 34 weeks of gestation (p = 0.005). Glycemic variability, assessed by MAGE, did not differ significantly according to ACS exposure, timing, or gestational age. Conclusions: Exposure to a complete and recent course of ACS is associated with an increased risk of early neonatal hypoglycemia in preterm infants, particularly within the first 24 hours of life. CGM enables detailed assessment of glycemic instability and may support improved metabolic monitoring in this high-risk population.
- 2 October 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1847988
Open AccessImpact of antenatal corticosteroid exposure on glycemic control in preterm infants assessed by continuous glucose monitoring: preliminary results from a single center study
Background: Antenatal corticosteroids (ACS) are routinely administered to women at risk of preterm delivery to improve neonatal respiratory outcomes. However, ACS exposure has been associated with neonatal hypoglycemia, and its impact on overall glycemic control and variability—particularly at earlier gestational ages—remains incompletely defined. Objectives: To evaluate glycemic control using continuous glucose monitoring (CGM) in preterm infants exposed to ACS and to assess the influence of timing of administration and gestational age on glycemic patterns. Methods: This prospective single-center cohort study included preterm infants born at 7 days) and gestational age (<34 vs ≥34 weeks). Statistical significance was adjusted using the Benjamini–Hochberg procedure. Results: Sixty-four infants were included (41 complete ACS, 15 partial ACS, 8 no ACS). Baseline characteristics were comparable among groups. During the first day of life, hypoglycemic events occurred exclusively in infants exposed to a complete course of ACS (p = 0.005), predominantly in those exposed within seven days prior to delivery. This difference was not observed on the second day. Hyperglycemic events were significantly more frequent in infants born before 34 weeks of gestation (p = 0.005). Glycemic variability, assessed by MAGE, did not differ significantly according to ACS exposure, timing, or gestational age. Conclusions: Exposure to a complete and recent course of ACS is associated with an increased risk of early neonatal hypoglycemia in preterm infants, particularly within the first 24 hours of life. CGM enables detailed assessment of glycemic instability and may support improved metabolic monitoring in this high-risk population.
- Open Access
- 30 September 2026
- Published by MDPI AG in Preprints.org
The Half of Everything: Glucose Imbalance Hazards and Brain Vulnerability at the Extremes of Life
Glucose is more than an energetic substrate: its homeostasis emerges from continuous interactions between peripheral glucose-regulatory organs and the brain, where glucose availability, sensing, and utilization must be dynamically matched to metabolic demands. This narrative review examines how disruption of this balance may intersect with oxidative stress, inflammation, and brain vulnerability at the extremes of life. In preterm neonates, the definition of pathological glycaemic states remains heterogeneous, while hypoglycaemia, hyperglycaemia, and particularly glycaemic variability may represent different manifestations of dysglycaemia within an immature homeostatic system. Experimental and clinical evidence links these disturbances, with different degrees of certainty, to oxidative stress, inflammatory responses, adverse neurological outcomes, and white matter vulnerability. The developing brain is particularly susceptible to redox imbalance because of maturation-dependent antioxidant defenses and the vulnerability of developing white matter. At the opposite extreme of life, aging is accompanied by alterations in cerebral glucose and energy metabolism, while neurodegenerative disorders show disturbances in glucose transport and utilization together with mitochondrial dysfunction, oxidative stress, inflammation, and neuronal and white matter abnormalities. We propose the Biochemical and Physiological Mirror as a conceptual interpretation of these apparently distant conditions: developmental immaturity and age-related decline represent distinct biological trajectories that may converge on partially shared glucose–redox–inflammatory intersections. Within the Crossword Effect, glucose therefore acquires biological meaning not as an isolated concentration but through its context-dependent relationships with metabolic, redox, inflammatory, cellular, and developmental information. Viewing dysglycaemia as a systems-level disturbance rather than solely as deviation from a numerical threshold may provide a more integrated framework for understanding brain vulnerability across the lifespan.
- 30 September 2026
- Published by MDPI AG in Preprints.org
Open AccessThe Half of Everything: Glucose Imbalance Hazards and Brain Vulnerability at the Extremes of Life
Glucose is more than an energetic substrate: its homeostasis emerges from continuous interactions between peripheral glucose-regulatory organs and the brain, where glucose availability, sensing, and utilization must be dynamically matched to metabolic demands. This narrative review examines how disruption of this balance may intersect with oxidative stress, inflammation, and brain vulnerability at the extremes of life. In preterm neonates, the definition of pathological glycaemic states remains heterogeneous, while hypoglycaemia, hyperglycaemia, and particularly glycaemic variability may represent different manifestations of dysglycaemia within an immature homeostatic system. Experimental and clinical evidence links these disturbances, with different degrees of certainty, to oxidative stress, inflammatory responses, adverse neurological outcomes, and white matter vulnerability. The developing brain is particularly susceptible to redox imbalance because of maturation-dependent antioxidant defenses and the vulnerability of developing white matter. At the opposite extreme of life, aging is accompanied by alterations in cerebral glucose and energy metabolism, while neurodegenerative disorders show disturbances in glucose transport and utilization together with mitochondrial dysfunction, oxidative stress, inflammation, and neuronal and white matter abnormalities. We propose the Biochemical and Physiological Mirror as a conceptual interpretation of these apparently distant conditions: developmental immaturity and age-related decline represent distinct biological trajectories that may converge on partially shared glucose–redox–inflammatory intersections. Within the Crossword Effect, glucose therefore acquires biological meaning not as an isolated concentration but through its context-dependent relationships with metabolic, redox, inflammatory, cellular, and developmental information. Viewing dysglycaemia as a systems-level disturbance rather than solely as deviation from a numerical threshold may provide a more integrated framework for understanding brain vulnerability across the lifespan.
- Open Access
- 30 September 2026
- Published by MDPI AG in Preprints.org
Beyond Similarity: A Developmental Framework for Translating Anti-Inflammatory Strategies in Neonatal White Matter Injury
Neonatal white matter injury (WMI) arises from the interaction of developmental vulnerability with hypoxic–ischaemic, inflammatory, oxidative, and metabolic perturbations. Although experimental models have substantially advanced the understanding of these mechanisms and supported the investigation of anti-inflammatory and neuroprotective strategies, their translation into neonatal clinical practice remains challenging. Neonates are neither small adults nor little children, and experimental animals are not scaled representations of human neonates. Similar molecular pathways, cellular targets, or anatomical features across species may therefore indicate concordance in individual characteristics without establishing biological or pharmacological equivalence. In this narrative review, we examine the translational gap between experimental models of neonatal WMI and human neonatal pharmacology, focusing on developmental differences in inflammatory pathways, white matter maturation, physiology, drug disposition, and target engagement. We discuss the apparent discordance between preclinical biological plausibility and clinical neuroprotection. Thereafter, we propose an intervention-specific framework (“The Reticulum Framework”) that organizes developmental concordance, evidence gaps and uncertainty across species; its predictive value requires empirical validation. The framework conceptualizes anatomy, physiology, biochemistry, and developmental pharmacology as interacting domains constrained by biophysical principles and introduces “comparative developmental physionemes” as biologically interpret descriptors whose concordance or discordance contributes to translational equivalence. In this sense, current validated biomarkers and surrogate measures could be used to analyse the interconnection between these domains across species, considering especially cellular and molecular dynamics through omics pipelines. The Reticulum Framework proposes that biological correspondence should be evaluated according to the functional meaning that a physioneme acquires within a specific developmental system rather than by isolated similarity. Translational relevance is therefore considered intervention-specific and is assessed across anatomical, physiological, biochemical, pharmacological, biophysical, temporal, and outcome concordance as a multidimensional profile. This framework may support model selection, interpretation of experimental anti-inflammatory efficacy, identification of translational mismatches, and prioritization of candidate neuroprotective interventions for neonatal trials.
- 30 September 2026
- Published by MDPI AG in Preprints.org
Open AccessBeyond Similarity: A Developmental Framework for Translating Anti-Inflammatory Strategies in Neonatal White Matter Injury
Neonatal white matter injury (WMI) arises from the interaction of developmental vulnerability with hypoxic–ischaemic, inflammatory, oxidative, and metabolic perturbations. Although experimental models have substantially advanced the understanding of these mechanisms and supported the investigation of anti-inflammatory and neuroprotective strategies, their translation into neonatal clinical practice remains challenging. Neonates are neither small adults nor little children, and experimental animals are not scaled representations of human neonates. Similar molecular pathways, cellular targets, or anatomical features across species may therefore indicate concordance in individual characteristics without establishing biological or pharmacological equivalence. In this narrative review, we examine the translational gap between experimental models of neonatal WMI and human neonatal pharmacology, focusing on developmental differences in inflammatory pathways, white matter maturation, physiology, drug disposition, and target engagement. We discuss the apparent discordance between preclinical biological plausibility and clinical neuroprotection. Thereafter, we propose an intervention-specific framework (“The Reticulum Framework”) that organizes developmental concordance, evidence gaps and uncertainty across species; its predictive value requires empirical validation. The framework conceptualizes anatomy, physiology, biochemistry, and developmental pharmacology as interacting domains constrained by biophysical principles and introduces “comparative developmental physionemes” as biologically interpret descriptors whose concordance or discordance contributes to translational equivalence. In this sense, current validated biomarkers and surrogate measures could be used to analyse the interconnection between these domains across species, considering especially cellular and molecular dynamics through omics pipelines. The Reticulum Framework proposes that biological correspondence should be evaluated according to the functional meaning that a physioneme acquires within a specific developmental system rather than by isolated similarity. Translational relevance is therefore considered intervention-specific and is assessed across anatomical, physiological, biochemical, pharmacological, biophysical, temporal, and outcome concordance as a multidimensional profile. This framework may support model selection, interpretation of experimental anti-inflammatory efficacy, identification of translational mismatches, and prioritization of candidate neuroprotective interventions for neonatal trials.
- Open Access
- 22 September 2026
- Published by MDPI AG in Pediatric Reports
- Vol. 18 (5) , 124
Early Exposure to Neonatal Neurology and Cranial Ultrasound: A Pilot Evaluation of an Undergraduate Course
Background/Objectives: Undergraduate medical exposure to neonatal neurology and cranial ultrasound remains limited, despite their relevance to neonatal clinical care. We developed a two-day monographic course integrating developmental neuroscience, neonatal clinical reasoning, neurological assessment, and bedside-oriented cranial ultrasound. This pilot study aimed to evaluate the acceptability, perceived educational relevance, and self-reported learning associated with the intervention. Methods: We conducted a single-center cross-sectional anonymous post-course evaluation among fourth- to sixth-year medical students at the University of Genoa, Italy, in October 2025. Seventeen students attended the course, and all completed an anonymous post-course questionnaire (response rate, 100%). The locally developed questionnaire included demographic items, five-point Likert-scale questions, categorical responses, retrospective self-ratings of knowledge before and after course attendance, and optional free-text comments. Descriptive statistics and 95% confidence intervals were calculated. Paired comparisons were performed using the Wilcoxon signed-rank test. Results: Seventeen students completed the questionnaire. The mean overall course evaluation was 4.18 ± 1.19/5 (95% CI 3.57–4.79) with a median rating of 5 (IQR 3–5), while perceived curricular relevance was rated 4.94 ± 0.24/5. The practical component received higher ratings than the theoretical component (4.88 ± 0.33 vs. 4.47 ± 0.62; median 5 [IQR 5–5] vs. 5 [IQR 4–5]; exploratory Wilcoxon signed-rank p = 0.020). Retrospective self-rated knowledge increased from 3.29 ± 1.10 before the course to 4.12 ± 0.70 after course completion (median 4 [IQR 4–5] vs. 3 [IQR 2–4]; exploratory p = 0.010). All respondents considered the educational format potentially applicable to other areas of the medical curriculum and 14/17 supported its replication within it. Eight respondents (47.1%) provided at least one optional free-text comment. Positive feedback highlighted the integration of theoretical and practical teaching and the small-group format, while suggestions included closer temporal integration of theory and practice (n = 3) and additional opportunities for direct hands-on cranial ultrasound experience (n = 2). Conclusions: This pilot course was highly acceptable and was associated with higher post-course knowledge self-ratings than retrospective pre-course ones. The practical cranial ultrasound component was particularly well received. A compact theory-to-practice format may offer an educational approach that was well accepted and perceived as valuable by participating students to introducing complex and underrepresented neonatal topics during undergraduate medical education. However, future multicenter studies incorporating objective learning outcomes and longer-term follow-up are needed.
- 22 September 2026
- Published by MDPI AG in Pediatric Reports
- Vol. 18 (5) , 124
Open AccessEarly Exposure to Neonatal Neurology and Cranial Ultrasound: A Pilot Evaluation of an Undergraduate Course
Background/Objectives: Undergraduate medical exposure to neonatal neurology and cranial ultrasound remains limited, despite their relevance to neonatal clinical care. We developed a two-day monographic course integrating developmental neuroscience, neonatal clinical reasoning, neurological assessment, and bedside-oriented cranial ultrasound. This pilot study aimed to evaluate the acceptability, perceived educational relevance, and self-reported learning associated with the intervention. Methods: We conducted a single-center cross-sectional anonymous post-course evaluation among fourth- to sixth-year medical students at the University of Genoa, Italy, in October 2025. Seventeen students attended the course, and all completed an anonymous post-course questionnaire (response rate, 100%). The locally developed questionnaire included demographic items, five-point Likert-scale questions, categorical responses, retrospective self-ratings of knowledge before and after course attendance, and optional free-text comments. Descriptive statistics and 95% confidence intervals were calculated. Paired comparisons were performed using the Wilcoxon signed-rank test. Results: Seventeen students completed the questionnaire. The mean overall course evaluation was 4.18 ± 1.19/5 (95% CI 3.57–4.79) with a median rating of 5 (IQR 3–5), while perceived curricular relevance was rated 4.94 ± 0.24/5. The practical component received higher ratings than the theoretical component (4.88 ± 0.33 vs. 4.47 ± 0.62; median 5 [IQR 5–5] vs. 5 [IQR 4–5]; exploratory Wilcoxon signed-rank p = 0.020). Retrospective self-rated knowledge increased from 3.29 ± 1.10 before the course to 4.12 ± 0.70 after course completion (median 4 [IQR 4–5] vs. 3 [IQR 2–4]; exploratory p = 0.010). All respondents considered the educational format potentially applicable to other areas of the medical curriculum and 14/17 supported its replication within it. Eight respondents (47.1%) provided at least one optional free-text comment. Positive feedback highlighted the integration of theoretical and practical teaching and the small-group format, while suggestions included closer temporal integration of theory and practice (n = 3) and additional opportunities for direct hands-on cranial ultrasound experience (n = 2). Conclusions: This pilot course was highly acceptable and was associated with higher post-course knowledge self-ratings than retrospective pre-course ones. The practical cranial ultrasound component was particularly well received. A compact theory-to-practice format may offer an educational approach that was well accepted and perceived as valuable by participating students to introducing complex and underrepresented neonatal topics during undergraduate medical education. However, future multicenter studies incorporating objective learning outcomes and longer-term follow-up are needed.
- Open Access
- 14 September 2026
- Published by MDPI AG in Preprints.org
The Glial Coupling in the Developing Brain: Astrocytes, Oligodendrocytes and Myelin Formation
Myelination in the developing brain emerges from a dynamic interplay among oligodendrocytes, astrocytes, neurons, vascular components, and immune cells. Although astrocyte–oligodendrocyte interactions are increasingly recognized as critical for myelin formation, maintenance, and metabolic homeostasis, their developmental organization remains incompletely understood, particularly in extremely preterm infants, in whom mature astrocytic functions are not yet fully established. This narrative review examines how oligodendrocyte maturation and white-matter metabolism may be supported across development and how perinatal insults can perturb this evolving cellular cooperation. Evidence from experimental, neuropathological, metabolic, and neuroimaging studies indicates that oligodendrocytes are not passive recipients of astrocytic support but active metabolic, signaling, and immunological partners whose functions evolve alongside astroglial maturation. In the immature white matter, this relationship is further shaped by neuronal activity, vascular substrate delivery, inflammatory signaling, and the intrinsic vulnerability of pre-oligodendrocytes. Hypoxia–ischemia, oxidative stress, iron dyshomeostasis, ferroptosis, and glycemic instability may therefore interfere with multiple components of this developing network. Human and experimental evidence from perinatal white-matter injury is particularly informative, showing the coexistence of reactive astrogliosis, pre-oligodendrocyte injury and maturation arrest, and subsequent impairment of myelination. Quantitative neuroimaging, radiomics, proteomics, and lipidomics provide complementary observational scales through which these processes may be investigated, although imaging markers of myelin remain biologically non-specific. Taken together, the available evidence does not support a single cellular substitute for mature astrocytic function. Rather, oligodendrocyte maturation appears to depend on a developmentally changing division of metabolic, homeostatic, and signaling labour across multiple cellular compartments. We propose that glial coupling itself should therefore be considered a developmentally constructed process whose disruption may contribute to white-matter vulnerability in the preterm brain.
- 14 September 2026
- Published by MDPI AG in Preprints.org
Open AccessThe Glial Coupling in the Developing Brain: Astrocytes, Oligodendrocytes and Myelin Formation
Myelination in the developing brain emerges from a dynamic interplay among oligodendrocytes, astrocytes, neurons, vascular components, and immune cells. Although astrocyte–oligodendrocyte interactions are increasingly recognized as critical for myelin formation, maintenance, and metabolic homeostasis, their developmental organization remains incompletely understood, particularly in extremely preterm infants, in whom mature astrocytic functions are not yet fully established. This narrative review examines how oligodendrocyte maturation and white-matter metabolism may be supported across development and how perinatal insults can perturb this evolving cellular cooperation. Evidence from experimental, neuropathological, metabolic, and neuroimaging studies indicates that oligodendrocytes are not passive recipients of astrocytic support but active metabolic, signaling, and immunological partners whose functions evolve alongside astroglial maturation. In the immature white matter, this relationship is further shaped by neuronal activity, vascular substrate delivery, inflammatory signaling, and the intrinsic vulnerability of pre-oligodendrocytes. Hypoxia–ischemia, oxidative stress, iron dyshomeostasis, ferroptosis, and glycemic instability may therefore interfere with multiple components of this developing network. Human and experimental evidence from perinatal white-matter injury is particularly informative, showing the coexistence of reactive astrogliosis, pre-oligodendrocyte injury and maturation arrest, and subsequent impairment of myelination. Quantitative neuroimaging, radiomics, proteomics, and lipidomics provide complementary observational scales through which these processes may be investigated, although imaging markers of myelin remain biologically non-specific. Taken together, the available evidence does not support a single cellular substitute for mature astrocytic function. Rather, oligodendrocyte maturation appears to depend on a developmentally changing division of metabolic, homeostatic, and signaling labour across multiple cellular compartments. We propose that glial coupling itself should therefore be considered a developmentally constructed process whose disruption may contribute to white-matter vulnerability in the preterm brain.
- 1 September 2026
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
Impact of a slow feeding advancement protocol on necrotizing enterocolitis incidence in preterm infants: A before‐and‐after study
Necrotizing enterocolitis (NEC) remains a major cause of morbidity and mortality in very low birth weight infants, while the safest rate of enteral feed advancement remains debated. We performed a retrospective single‐center before‐after cohort study in a tertiary neonatal intensive care unit, comparing two feeding strategies in 572 infants (286 per group): faster advancement (20–30 mL/kg/day) from 2015–2018 and slower advancement (10–25 mL/kg every 48 h, weight‐dependent) from 2020–2023. The primary outcome was NEC, defined as Bell stage ≥IIb or diagnosis at surgery. NEC was less frequent in the slower‐advancement era (2.1% vs 7.9%; adjusted p = 0.02). Mortality, late‐onset sepsis, central venous catheter duration, and extrauterine growth restriction were similar. Faster advancement led to earlier full enteral feeding, while discharge weight centiles were comparable. A cautious feeding strategy was associated with lower NEC incidence without evidence of worse infectious or growth outcomes.
- 1 September 2026
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
Impact of a slow feeding advancement protocol on necrotizing enterocolitis incidence in preterm infants: A before‐and‐after study
Necrotizing enterocolitis (NEC) remains a major cause of morbidity and mortality in very low birth weight infants, while the safest rate of enteral feed advancement remains debated. We performed a retrospective single‐center before‐after cohort study in a tertiary neonatal intensive care unit, comparing two feeding strategies in 572 infants (286 per group): faster advancement (20–30 mL/kg/day) from 2015–2018 and slower advancement (10–25 mL/kg every 48 h, weight‐dependent) from 2020–2023. The primary outcome was NEC, defined as Bell stage ≥IIb or diagnosis at surgery. NEC was less frequent in the slower‐advancement era (2.1% vs 7.9%; adjusted p = 0.02). Mortality, late‐onset sepsis, central venous catheter duration, and extrauterine growth restriction were similar. Faster advancement led to earlier full enteral feeding, while discharge weight centiles were comparable. A cautious feeding strategy was associated with lower NEC incidence without evidence of worse infectious or growth outcomes.